Cargando…
Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion
Heparan sulfate (HS) proteoglycans (HSPGs) are abundant glycoconjugates in cells’ glycocalyx and extracellular matrix. By acting as scaffolds for protein–protein interactions, HSPGs modulate extracellular ligand gradients, cell signaling networks, and cell–extracellular matrix crosstalk. Aberrant ex...
Autores principales: | Marques, Catarina, Poças, Juliana, Gomes, Catarina, Faria-Ramos, Isabel, Reis, Celso A., Vivès, Romain R., Magalhães, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637574/ https://www.ncbi.nlm.nih.gov/pubmed/36181793 http://dx.doi.org/10.1016/j.jbc.2022.102546 |
Ejemplares similares
-
The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination
por: Pu, Annie, et al.
Publicado: (2020) -
The structure of EXTL3 helps to explain the different roles of bi-domain exostosins in heparan sulfate synthesis
por: Wilson, L. F. L., et al.
Publicado: (2022) -
Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression
por: Marques, Catarina, et al.
Publicado: (2021) -
EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome
por: Canals, Isaac, et al.
Publicado: (2015) -
Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management
por: Faria-Ramos, Isabel, et al.
Publicado: (2021)